Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$17.60 -0.62 (-3.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Depreciation and Depletion (2026)

Updated

Syndax Pharmaceuticals (SNDX) posted Depreciation and Depletion of $5 million for Q2 2026, up 25.0% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Depreciation and Depletion (2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation and Depletion at Syndax Pharmaceuticals was $9 million; for FY2025, it was $6 million, down 25.0% from FY2024.

  • Annual Depreciation and Depletion has declined for four consecutive years, though with a five-year compound annual growth rate of 131.6% (FY2020 to FY2025).
  • In prior years, Syndax Pharmaceuticals' Depreciation and Depletion was $8 million in FY2024 (-33.3%), $12 million in FY2023 (-63.6%), $33 million in FY2022 (-23.3%) and $43 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Syndax Pharmaceuticals 1.57 Bn -160.92 Mn 69.58 Mn 5.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.00 Mn
Mar 31, 2026 4.00 Mn
API Access

Syndax Pharmaceuticals Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=SNDX&period=max&api_key=YOUR_API_KEY